Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherWages, Salaries and Other
Ratios

Capricor Therapeutics (CAPR) Receivables - Other (2016 - 2025)

Capricor Therapeutics has reported Receivables - Other over the past 13 years, most recently at $59167.0 for Q4 2025.

  • Quarterly results put Receivables - Other at $59167.0 for Q4 2025, down 99.43% from a year ago — trailing twelve months through Dec 2025 was $59167.0 (down 99.43% YoY), and the annual figure for FY2025 was $59167.0, down 99.41%.
  • Receivables - Other for Q4 2025 was $59167.0 at Capricor Therapeutics, roughly flat from $59167.0 in the prior quarter.
  • Over the last five years, Receivables - Other for CAPR hit a ceiling of $10.4 million in Q4 2023 and a floor of $59167.0 in Q3 2025.
  • Median Receivables - Other over the past 5 years was $400716.0 (2021), compared with a mean of $1.4 million.
  • Biggest five-year swings in Receivables - Other: surged 1794.15% in 2023 and later tumbled 99.43% in 2025.
  • Capricor Therapeutics' Receivables - Other stood at $391750.0 in 2021, then skyrocketed by 39.78% to $547580.0 in 2022, then surged by 1794.15% to $10.4 million in 2023, then decreased by 0.03% to $10.4 million in 2024, then tumbled by 99.43% to $59167.0 in 2025.
  • The last three reported values for Receivables - Other were $59167.0 (Q4 2025), $59167.0 (Q3 2025), and $59509.0 (Q2 2025) per Business Quant data.